Astera Labs (NASDAQ:ALAB) Stock Price Down 1.9% – Should You Sell?

Astera Labs, Inc. (NASDAQ:ALAB)’s stock price was down 1.9% on Wednesday. The stock traded as low as $360.22 and last traded at $382.25. 4,990,725 shares were traded during trading, a decline of 4% from the average daily volume of 5,190,657 shares. The stock had previously closed at $389.80.

Key Astera Labs News

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Astera Labs introduced Aries 7, which it describes as the industry’s first PCIe 7 signal-conditioning portfolio spanning copper and optical interconnects. The product family includes retimers, redrivers, cable modules, optical drivers and optical transimpedance amplifiers designed for AI infrastructure. The launch expands ALAB’s addressable market and strengthens its positioning in high-speed connectivity for AI systems. Astera Labs Announces Aries 7
• Positive Sentiment: Analysts view Aries 7 as part of Astera Labs’ broader push to benefit from surging AI connectivity demand. The portfolio could help ALAB compete more directly with Marvell Technology and Credo Technology, while its optical products may give the company additional exposure to next-generation AI data-center architectures. ALAB Expands PCIe Portfolio With Aries 7
• Neutral Sentiment: Marvell’s projection that connecting AI chips could become a $37 billion business supported the broader AI-connectivity investment theme and highlighted potential demand for companies such as ALAB. However, the coverage also noted Astera Labs’ reliance on a limited number of major customers and its elevated valuation, increasing execution risk. Marvell Says Connecting AI Chips Could Be a $37 Billion Business
• Negative Sentiment: Northland Securities downgraded ALAB from “outperform” to “market perform,” signaling reduced near-term upside after the stock’s substantial rally.
• Negative Sentiment: Jim Cramer said he likes Astera Labs’ business but believes the shares are too expensive. That warning reinforces valuation concerns, with the stock trading at a very high earnings multiple despite strong growth expectations. Jim Cramer Likes This Stock but Has a Problem With the Price

Wall Street Analysts Forecast Growth

Several analysts have commented on the stock. Citigroup downgraded shares of Astera Labs from a “buy” rating to a “market perform” rating in a report on Friday. Weiss Ratings reissued a “hold (c)” rating on shares of Astera Labs in a research report on Tuesday, August 18th. TD Cowen dropped their price objective on shares of Astera Labs from $425.00 to $375.00 and set a “hold” rating on the stock in a report on Wednesday, August 5th. Susquehanna boosted their price objective on shares of Astera Labs from $230.00 to $275.00 and gave the company a “neutral” rating in a research report on Friday, July 31st. Finally, Jefferies Financial Group upped their target price on shares of Astera Labs from $270.00 to $450.00 and gave the stock a “buy” rating in a research note on Wednesday, August 5th. Ten investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $348.33.

Astera Labs Stock Performance

The business has a 50-day simple moving average of $316.82 and a two-hundred day simple moving average of $290.03. The stock has a market cap of $59.05 billion, a price-to-earnings ratio of 168.68 and a beta of 3.68.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. The company had revenue of $392.40 million for the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm’s revenue was up 104.5% compared to the same quarter last year. During the same period last year, the company earned $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, analysts expect that Astera Labs, Inc. will post 2.7 earnings per share for the current fiscal year.

Insider Transactions at Astera Labs

In other Astera Labs news, General Counsel Philip Mazzara sold 6,801 shares of the business’s stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the sale, the general counsel directly owned 96,542 shares of the company’s stock, valued at $32,872,551. The trade was a 6.58% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Sanjay Gajendra sold 90,630 shares of the stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the transaction, the chief operating officer owned 1,119,038 shares of the company’s stock, valued at approximately $380,864,583.30. This represents a 7.49% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last ninety days, insiders sold 396,059 shares of company stock worth $122,605,660. 10.40% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the stock. BlackRock Inc. bought a new stake in shares of Astera Labs during the 2nd quarter worth approximately $6,609,581,000. Atreides Management LP grew its stake in shares of Astera Labs by 108.9% in the first quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock valued at $368,890,000 after buying an additional 1,754,593 shares in the last quarter. Van ECK Associates Corp increased its holdings in Astera Labs by 20.0% during the second quarter. Van ECK Associates Corp now owns 2,237,961 shares of the company’s stock worth $1,080,980,000 after buying an additional 373,545 shares during the last quarter. Bank of America Corp DE acquired a new position in Astera Labs during the second quarter worth $1,061,791,000. Finally, Fred Alger Management LLC raised its position in Astera Labs by 25.5% during the fourth quarter. Fred Alger Management LLC now owns 1,934,688 shares of the company’s stock worth $321,855,000 after acquiring an additional 393,250 shares in the last quarter. 60.47% of the stock is owned by institutional investors and hedge funds.

About Astera Labs

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data centers connect and manage processors, memory, storage, and networking components in high-performance computing systems.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) smart memory controllers, Scorpio PCIe switches, Taurus Ethernet fabric switches, and Leo CXL memory connectivity products.